Pricing Log in Create free account
Saturday 17 October 2026 Export SRTA’s income statement to Excel — free account

Strata Critical Medical, Inc.

SRTA Healthcare Medical Care Facilities

In the quarter to June 2026, revenue grew 60.7%, EPS fell 140.0% and free cash flow grew 150.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

4.54 0.20 +4.61%
Market cap
$384.0M
P/E
9.0×
Fwd P/E
−145×
Dividend yield
—
F-score
5/9
Altman Z
5.25
Beneish M
−0.84
Dividend safety
n/a
Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.10
Total sells 0.93
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — 2 — — — — — — — — — —
Sell 2 — — — — — 2 4 — 1 — —
Insider Ownership 22.95%

Capital & Financial Ratios $m

Market Cap 383.95
Revenue 255.98
Net Income 40.22
Free Cash Flow (49.52)
Net Debt (23.02)
Current Ratio 2.64 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 8.95
Fwd P/E (145.00) (negative: loss-making)
P/S ratio 1.53
P/B ratio 1.40
Past 5Y EPS Growth 100.32% (at or above 15%: strong)
This Y EPS Growth 63.39% (at or above 15%: strong)
Next Y EPS Growth 103.60% (at or above 15%: strong)
Next Y revenue growth 47.51% (at or above 10%: strong)
Next 5Y EPS Growth 55.32% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.4×, against a ten-year median of 1.1×; over the ten years it ranged from −0.3× in 2022 to 6.9× in 2021.
P/S against its own 10 years 30.50%
10-year low 10-year high
P/B against its own 10 years 54.41%
10-year low 10-year high
EV/Sales against its own 10 years 62.63%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2020 Powerpack
2019 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 167 125 61 23
Receivables 21 20 40 43
Inventory — — — —
Other — — — —
206 161 126 121
2023 2024 2025 Q'26
Payables 24 9 19 18
ST’ Debt — — — —
Other — — — 26
35 23 20 46

Compound Annual Growth %

10y 5y 3y
Sales — 31.30% 10.50%
Cash Flow — 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value — (0.85%) 0.55%

Revenue $m

Mar Jun Sep Dec Year
’26 67 73 — — —
’25 36 45 49 67 197
’24 52 68 36 — 147
’23 45 61 71 47 225
’22 27 36 46 38 146
’21 — — — 33 75
’21 9 13 20 17 51
Fiscal quarters ending in the months shown.
value withheld pending a data check

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 4 6 — — —
’25 0 (3) (37) (8) (49)
’24 (16) 8 6 (2) (3)
’23 (17) (8) 2 (9) (32)
’22 (10) (12) (6) (9) (37)
’21 — — — (6) (22)
’21 (1) (9) (6) — (16)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) 3 — — —
’25 (3) (6) (40) (10) (60)
’24 (17) (8) (4) (7) (35)
’23 (18) (9) 1 (9) (34)
’22 (11) (12) (6) (9) (38)
’21 — — — (19) (35)
’21 (1) (9) (6) — (16)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.03 (0.12) — — —
’25 (0.04) (0.05) 0.70 (0.10) 0.50
’24 (0.06) (0.15) (0.03) (0.12) (0.35)
’23 (0.14) (0.17) 0.00 (0.45) (0.76)
’22 (0.16) 0.10 (0.13) (0.21) (0.38)
’21 — — — 0.01 (0.93)
’21 (0.16) (0.47) (0.13) — (0.93)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — 9.70 9.28 6.41 3.02 2.06 2.45 2.35

Analyst estimates 2026–2028

Powerpack
High — — — 9.85 12.05 19.88 9.90 5.10 5.17 6.02
People
People Employees — — — — — 133 246 281 322 601
Revenue/emp, $m — — 0.00 0.00 0.00 0.00 0.59 0.80 0.46 0.33
Income, $m
Income, $m Revenue — — 31 31 23 75 146 225 147 197
Gross margin, % — — 15.06 15.06 9.93 19.24 15.24 18.71 20.15 20.86
EBT — — (11) 1 0 (43) (28) (58) (16) (20)
EBT margin, % — — (34.74) 0.00 0.00 (57.27) (19.18) (25.55) (11.01) (10.18)
Net income — 0 0 1 0 (39) (27) (56) (27) 41
Depreciation — — — 0 1 1 6 7 6 8
Per share, $
Per share, $ Revenue — — 0.00 0.00 0.00 1.75 2.05 3.06 1.89 2.40
Earnings — — — 0.11 0.02 (0.93) (0.38) (0.76) (0.35) 0.50
Cash flow — — — (0.04) (0.10) (0.50) (0.52) (0.44) (0.03) (0.60)
Capex — — — 0.00 0.00 (0.30) (0.01) (0.03) (0.43) (0.13)
Free cash flow — — — (0.04) (0.10) (0.80) (0.53) (0.47) (0.46) (0.73)
Book value — — 0.00 0.70 0.61 6.79 3.85 3.19 2.86 3.40
Shares, m — — — 7 8 43 71 74 77 82
Valuation, ×
Valuation, × P/E — — 491.50 491.50 15.45 0.00 0.00 0.00 0.00 9.49
P/S — — 0.00 0.00 0.00 5.04 1.65 1.11 2.24 2.00
P/B — — 12.72 12.72 7.45 1.30 0.88 1.07 1.48 1.41
EV/Sales — — 0.00 0.00 0.00 1.28 0.31 0.37 1.39 1.69
EV/FCF — — 0.00 0.00 (104.74) (4.34) (1.20) (2.43) (5.75) (5.56)
Cash, $m
Cash, $m Operating cash flow — — — 0 (1) (22) (37) (32) (3) (49)
Capex — — — (1) 0 (13) (1) (2) (33) (11)
Free cash flow — — — 0 (1) (35) (38) (34) (35) (60)
Balance, $m
Balance, $m Working capital — — 275 1 1 282 192 171 138 106
Total debt — — — — — 1 18 — — —
Net debt — — (276) (1) (1) (283) (195) (167) (125) (61)
Shareholders’ equity — — 5 5 5 291 274 234 222 279
Returns, %
Returns, % ROA — — (7.88) 0.28 0.09 (11.57) (8.25) (18.09) (9.90) 14.21
ROIC — — 0.00 (4.54) (10.21) (246.73) (42.17) (63.53) (14.54) (6.42)
ROE — — 0.00 27.13 1.59 (13.48) (9.63) (22.04) (11.97) 16.51
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 28 Sep 2026

Charts ten years each

Strata Critical Medical, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
NUTX Nutex Health Inc. $1.4B 7.1× 6.3× −13.62% (below 0%: shrinking) n/m +19.44% (above 0%: growing) 67.04% 57.75% Compare
USPH U.S. Physical Therapy, Inc. $1.3B 504× 27.7× +8.47% (above 0%: growing) −56.90% (below 0%: shrinking) −8.24% (below 0%: shrinking) 19.59% 10.25% Compare
INNV InnovAge Holding Corp. $1.2B — (loss-making) 17.2× +18.31% (above 0%: growing) n/m +85.44% (above 0%: growing) 23.88% 3.87% Compare
STLN Starling Oncology, Inc. $690.9M — (loss-making) — (loss-making) +34.62% (above 0%: growing) n/m +196.69% (above 0%: growing) 16.84% (2.86%) Compare
MCTA Charming Medical Limited $497.3M — — — — — — — Compare
CYH Community Health Systems, Inc. $421.6M 1.5× — (loss-making) −9.83% (below 0%: shrinking) −75.83% (below 0%: shrinking) +500.00% (above 0%: growing) 85.81% 13.77% Compare
AUNA Auna S.A. $392.3M 76.0× 5.2× +20.51% (above 0%: growing) −61.29% (below 0%: shrinking) +121.08% (above 0%: growing) 35.72% 13.09% Compare
SRTA Strata Critical Medical, Inc. $384.0M 9.0× — (loss-making) +60.74% (above 0%: growing) n/m +150.33% (above 0%: growing) 20.98% (7.46%)
AIRS AirSculpt Technologies, Inc. $102.0M — (loss-making) — (loss-making) −2.53% (below 0%: shrinking) n/m −131.07% (below 0%: shrinking) 61.38% (0.07%) Compare
Median of peers $594.1M 41.6× 11.7× +8.47% −61.29% +85.44% 35.72% 10.25%

All 55 Medical Care Facilities stocks →

Strata Critical Medical, Inc. (SRTA) key facts

  • Strata Critical Medical, Inc. (SRTA) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, SRTA traded at $4.54, a market capitalization of $384.0 million.
  • Return on equity was 16.5% and debt-to-equity 0.00.
  • Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 5.25 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations · fundamentals updated Sep 28, 2026.

Strata Critical Medical, Inc. (SRTA) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/SRTA · Data as of Sep 28, 2026 · For information only; not investment advice. · © 2026 stockrow.com